Toronto Innovation Acceleration Partners
Venture studioToronto · Pre-Seed–Seed · 11 people tracked
Investment thesis
TIAP focuses on venture building of early-stage health science technologies emerging from its academic member institutions. It transforms early-stage scientific innovations into business ventures, de-risks ideas through expert financial and scientific advice, invests in early-stage innovations, and sources external venture capital for future funding. TIAP leverages a global and local network to connect industry, researchers, investors and members. It offers cornerstone programs and management support including LAB150-NextGen, UTEST, Venture Builder, Critical Technologies and Portfolio Management to advance inventions toward a market-ready state.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from the firm's websiteWhat they invest in
from 28 of 45 portfolio companiesBiotech ×13Healthtech ×11Medical Devices ×11AI & Machine Learning ×9Deep Tech ×7Digital Health ×4Cleantech ×2Cloud Computing ×2
HQs:Canada×8
Investments · 45 tracked
founders shown can be your intro path7D Surgical develops image-guided surgical navigation systems using machine-vision technology for spine, cranial, and percutaneous procedures.
AI & Machine LearningHealthtechMedical Devices
STEPHEN MARTIN(Executive Officer)MICHAEL CADOTTE(Director)VICTOR YOUNG(Executive Officer, Director)ADRIAN LINUS DINESH MARIAMPILLAI(Executive Officer, Director)MICHAEL APKON(Director)BEAU STANDISH(Executive Officer, Director)
AmacaThera develops a tunable hydrogel drug-delivery platform for long-acting therapeutic administration across various clinical applications, including pain management, oncology, and post-surgical care.
BiotechMedical Devices
Bright Angel Therapeutics develops novel small molecule therapeutics for treating drug-resistant and life-threatening fungal infections using computational drug discovery and proprietary fungal-selective inhibitor technologies.
BiotechDeep TechMedical DevicesToronto, CA
Dalriada works on covalent drug discovery through collaborations with research institutions like Cleveland Clinic Center for Therapeutics Discovery.
BiotechDeep TechMedical Devices
Damona Pharma develops therapies targeting cognitive deficits by using positive allosteric modulators to restore neural connections and improve brain cell communication.
BiotechHealthtechMedical Devices
EBT Medical develops neuromodulation technologies targeting the Saphenous nerve to treat pelvic health disorders, particularly overactive bladder.
BiotechMedical Devices<UNKNOWN>, CA
Paul Yoo(Co-founder, President & Chief Scientific Officer)Sasha John(Co-founder and Chief Innovation Officer)Keith R Carlton(Chief Executive Officer)
Lorica.ai provides a platform for deploying AI models with confidential computing and privacy protections, enabling users from individual developers to enterprises to run secure AI workloads without performance degradation.
AI & Machine LearningCloud ComputingCybersecurity
Medly provides a Class II medical device application and dashboard for remote monitoring and management of chronic conditions, particularly heart failure, for patients and their care teams.
Digital HealthHealthtechMedical DevicesCanada, CA
Autoscribe is an AI-powered digital scribe that transcribes clinician-patient conversations and automatically generates medical notes for physicians.
AI & Machine LearningDigital HealthHealthtechOntario, CA
Canadian medical doctor
Pearl Interactives develops interactive games and experiences for children that combine physical movement, music, and creative learning with technology like mixed reality and touch-free interfaces.
EdTechGamingHealthtech
Phenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology.
AI & Machine LearningBiotechDeep TechToronto, CA
Sam Cooper(Co-founder & CTO)Oren Kraus(Co-founder)
Phycus Bio produces Purolic Acid™, a biobased glycolic acid made through fermentation using renewable, FSC-certified wood feedstock for cosmetic, personal care, adhesive, coating, and polymer applications.
BiotechCleantechNew Materials
QurCan Therapeutics develops nanoparticle drug delivery technology called TERP to create nanomedicines for cancer and central nervous system diseases, with a focus on improving tissue targeting and reducing toxicity associated with existing approaches.
BiotechDeep TechMedical Devices
Radialis develops the Radialis PET Imager, an organ-targeted positron emission tomography system for high-resolution medical imaging of specific tissues and organs.
Deep TechHealthtechMedical Devices
Wayne SchnarrAlla ReznikAndrew DeanCarmel ShieldsPeyvand Melati
Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.
BiotechMedical Devices
Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)
Tabiat provides a remote care program for COPD (chronic obstructive pulmonary disease) management, offering home monitoring via mobile app, nursing team support, and patient education to reduce hospital readmissions.
Digital HealthHealthtech
Vasomune Therapeutics develops investigational medicines, including AV-001, which has received US FDA Fast Track designation.
Biotech<UNKNOWN>
Frequently asked questions
- What stage does Toronto Innovation Acceleration Partners invest at?
- Toronto Innovation Acceleration Partners invests at the Pre-Seed, Seed stages.
- What sectors does Toronto Innovation Acceleration Partners focus on?
- Toronto Innovation Acceleration Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Toronto Innovation Acceleration Partners located?
- Toronto Innovation Acceleration Partners is headquartered in Toronto, CA.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital is a venture and growth investment firm that backs technology companies, including a dedicated Resilience Tech practice focused on energy, industrial and infrastructure systems.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.










